What Brainjo does

Brainjo (legal entity brainjo GmbH) is a Regensburg, Germany-based digital health company founded in 2020 as a spin-out of Ostbayerische Technische Hochschulen (OTH Regensburg). It develops VR-based digital therapeutics (DTx) delivered through Meta Quest 2 hardware, with a lead product BJ-101 VR HyperHero — a 24-session, 5-module, 3-month gamified VR therapy for children aged 8-13 with ADHD, built on evidence-based psychotherapy content adapted with key opinion leaders Prof. Dr. Manfred Döpfner and Prof. Dr. Anja Görtz-Dorten of the AKiP Institute at the University of Cologne. The company is pursuing German DiGA (Digital Health Application) approval with planned market entry in 2028 and a target reimbursement price of approximately €250 per prescription covered by statutory health insurers.

The business is built around two complementary revenue tracks. The regulated DTx track bundles BJ-101 ADHD and a pipeline of eight additional candidates spanning phobias, hearing loss, depression, childhood obesity, autism, cognitive decline, chronic pain, and dialysis-related cognitive decline (BJ-102 through BJ-109), supported by a strategic co-development partnership with MEDICE – The Health Family and clinical study infrastructure targeting a 2025 study start. The corporate health track sells VR BOX (portable case-based) and VR HUB (stationary touchscreen kiosk) hardware alongside VR brain-training applications, 10-week mental fitness programs, and on-site Health Day events priced at €1,499.96, with reimbursement pathways via German health insurers under §20 SGB V. Go-to-market mixes direct enterprise field sales to German corporations for BGM (Betriebliches Gesundheitsmanagement), clinical/hospital distribution pending DiGA listing, community-led engagement through a WhatsApp-based ADHD family community of 70+ families, and event-driven demand generation at trade fairs and corporate health days.

The company is venture-backed by HTGF High-Tech Gründerfonds (lead investor across both rounds), MEDICE – The Health Family, and angel investors from better ventures, with total disclosed equity and grant funding exceeding €3.7 million (€1.05M pre-seed + €650K European/state grants in early 2024; €2M seed in April 2026). Brainjo employs 11-13 people across VR development, game design, product/regulatory, legal, and management functions, supplemented by an advisory board spanning DTx commercialization (ex-Kaia Health), digital health consulting (_fbeta), neurotechnology (g.tec), gaming production (ex-Warner Bros. Games/Disney), and Meta public policy.

Name

Brainjo

Legal name

brainjo GmbH

Website

https://brainjo.de

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Brainjo is a Regensburg, Germany-based digital health company developing VR-based digital therapeutics, with its lead product BJ-101 VR HyperHero targeting children aged 8-13 with ADHD. It pursues German DiGA reimbursement (planned for 2028) and additionally sells VR BOX and VR HUB hardware for corporate workplace wellness programs.

Ownership category

akta.pro rank

Product category

Digital Therapeutics

NAICS

Research and Development in the Social Sciences and Humanities (54172), Scientific Research and Development Services (5417)

SIC

Services-Prepackaged Software (7372), Services-Computer Programming Services (7371)

akta.pro primary industry

Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)

Keywords

• VR digital therapeutics
• ADHD therapy software
• Corporate wellness VR
• Digital health applications
• VR cognitive training

Headquarters

HQ city

Regensburg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Operations

Revenue model

1. VR BOX and VR HUB Hardware Sales: Sale/rental of VR hardware packages including Meta Quest 2 headsets in portable cases (VR BOX) or fixed stations (VR HUB). VR BOX from 3-month rental contracts; VR HUB available for on-site corporate use.
2. Health Day Events: Corporate health day events at €1,499.96, including VR training sessions, expert consultation, and personalized 10-week exercise plans. Can serve 30-40 participants per day with health insurance reimbursement possible.
3. Enterprise Software Subscriptions: Enterprise tier includes 10-week Mental Fit Program with progress tracking, competition and motivation app. Individual tier offers custom VR application development from €3,000.
4. DiGA (Digital Health Application) Revenue: Planned reimbursement through German health insurance (Krankenkassen) for VR-based digital therapeutics. Estimated cost of approximately €250 per prescription for anxiety disorders DiGA. Market approval planned for 2028.
5. Corporate Health BGM Programs: Ongoing corporate wellness programs combining cognitive training with physical exercises for employee mental fitness. Funded through health insurance cooperation under §20 SGB V.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

Core offering

Brainjo develops VR-based digital therapeutics (DTx) — primarily the BJ-101 VR HyperHero program for children with ADHD (aged 8-13), with a pipeline of nine therapeutic candidates spanning phobias, depression, hearing loss, obesity, autism, cognitive decline, chronic pain and dialysis-related cognitive decline. In parallel, the company runs a Corporate Health division that sells VR BOX and VR HUB hardware bundles, delivers on-site corporate Health Day events, and licenses a 10-week Mental Fit corporate brain-training program combining cognitive and physical exercises.

Product overview

Brainjo is a digital health platform offering VR-based digital therapeutics (DTx) through a pipeline of therapeutic candidates targeting various conditions. The core products include BJ-101 VR HyperHero for ADHD in children (the lead product in clinical development) and additional VR therapies for phobias, depression, childhood obesity, autism, cognitive decline, chronic pain, and dialysis complications in various development stages. The company also offers a Corporate Health division with VR BOX and VR HUB hardware products for workplace wellness, including brain training applications, mindfulness programs, and corporate health day events. All therapeutic products aim for DiGA (Digital Health Application) approval for health insurance reimbursement in Germany.

Differentiator

Problem solved

Functional benefit

Products and services

• BJ-101 VR HyperHero VR-based digital therapy application for children with ADHD aged 8-13, consisting of 5 modules across 24 sessions (~40 min each) over approximately 3 months. Delivers evidence-based psychotherapy through gamified immersive VR worlds, co-developed with key ADHD opinion leaders and aimed at DiGA reimbursement.
• BJ-102 VR Phobien VR-based DiGA for treatment of anxiety disorders and phobias using evidence-based behavioral therapy with exposure elements; targeted for ICD-10 conditions F40.0, F40.1 and F40.2, with planned 100% German health-insurance reimbursement.
• VR BOX Mobile VR solution packaged in a portable stainless-steel case containing a Meta Quest 2 headset with controller, app access, manuals and posters; sold or rented from 3-month contract terms for decentralized corporate health, trade shows and gymnasiums.
• VR HUB Stationary VR station with a 15-inch touchscreen display on Android OS, Meta Quest 2 headset with magnetic charging, and mobile design on casters; intended for on-site use in companies, fitness studios and hotels.
• Corporate Health Applications Suite of VR applications for corporate health management combining cognitive tasks with physical exercises; includes a 10-week mindfulness program, plus memory, reaction, decision-making, movement-memory, hand-eye coordination and spatial-reasoning exercises.
• Gesundheitstag (Health Day) On-site corporate health day event featuring ~10-minute VR brain-training sessions per participant, consultation with psychologists and sports scientists, a personalized 10-week exercise plan and individual training folders; priced at €1,499.96 per event with up to 100% reimbursement via German §20 SGB V health-insurance funding.

Quantifiable outcome

• 10-minute brain training burns approximately 148 calories at over 80% of maximum heart rate (aerobic training zone)
• +5 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• MEDICE – The Health FamilycoreStrategic or Co-development PartnerCo-development partner for BJ-101 VR HyperHero ADHD DiGA. Strategic collaboration to bring VR-based ADHD therapy to market with pharmaceutical industry expertise and market access.
• Ostbayerische Technische Hochschulen (OTH Regensburg)coreStrategic or Co-development PartnerUniversity spin-out origin. brainjo was founded from OTH Regensburg and an ADHD initiative, maintaining ongoing research relationships with the university.
• Prof. Dr. Anja Görtz-DortencoreStrategic or Co-development PartnerLeading ADHD Key Opinion Leader (KOL) and Head of AKiP Institute at University of Cologne. Collaborated on evidence-based content development for VR ADHD therapy, adapting therapy manuals for immersive VR experience.
• Prof. Dr. Manfred DöpfnercoreStrategic or Co-development PartnerFormer Head of AKiP Institute at University of Cologne, psychologist, psychotherapist, and author. Collaborated on evidence-based content development for VR ADHD therapy.
• Fernuniversität HagenminorStrategic or Co-development PartnerResearch collaboration on BJ-103 VR Cochlea project for inner ear hearing loss treatment using VR technology.
• _fbeta (Digital Health Consulting)minorStrategic or Co-development PartnerDigital health consulting partner. Jonas Albert, Partner at fbeta, serves on advisory board with expertise in DiGA/DiPA market. Member of DTx Consulting Alliance.
• Kinder- und Jugendhilfe RegensburgminorImplementation/ SI/ Consulting PartnerChild and youth welfare organization in Regensburg. Clinical psychologist Julia Punk collaborates on therapy development and provides practical feedback from therapy settings.
• Gallium StudiosminorStrategic or Co-development PartnerGaming expertise collaboration. Timothy Johnson, ex-Technical Director at WB Games (Harry Potter), Disney, serves as gaming expert on advisory board to ensure engaging gamification.

Scale indicators6 records

Recent moves4 records

Expansion highlights5 records

Regional players

• Selfapy: Selfapy is a Berlin-based DTx provider with DiGA-listed courses for depression, burnout and anxiety. It is a regional German competitor in the digital mental health reimbursement space adjacent to Brainjo's BJ-101, BJ-102 and BJ-104 assets.
• HelloBetter: HelloBetter (formerly GET.ON) is a German digital therapeutics company with multiple DiGA-listed products for mental health. It is a direct regional peer in the German DiGA mental health category and a key competitor for physician adoption and reimbursement positioning.

Direct peers

• BehaVR: BehaVR develops immersive VR-based digital therapeutics for behavioral and mental health conditions (anxiety, chronic pain, oncology support). It is a direct peer in VR-DTx modality and overlaps with Brainjo's anxiety (BJ-102) and chronic pain (BJ-108) pipeline assets.
• Kaia Health: Kaia Health is a digital therapeutics company with DiGA-listed products in Germany for MSK pain and COPD. Advisory board member Dr. Stephan Huber is a former Kaia Health DTx expert, making Kaia both a direct DTx peer in Germany and an important prior employer signaling industry credibility.
• Akili Interactive: Akili Interactive is a digital therapeutics company with an FDA-cleared prescription video game treatment (EndeavorRx) for pediatric ADHD. It is the closest direct competitor to Brainjo's BJ-101 VR HyperHero in indication, modality and patient age range, and represents the regulatory and commercial benchmark Brainjo is targeting via the DiGA pathway.
• XRHealth: XRHealth operates a VR-based telehealth platform delivering clinician-supervised therapy for anxiety, ADHD, cognitive rehabilitation and pain — directly overlapping with Brainjo's clinical use cases and VR-modality approach.
• Sympatient: Sympatient is a German startup offering VR-based exposure therapy for anxiety disorders and phobias, and is a DiGA-listed competitor. It is a direct regional peer to Brainjo's BJ-102 VR Phobien anxiety product in the German payer market.

Broad incumbents

• Big Health: Big Health (Sleepio, Daylight) is a leading digital therapeutics company for insomnia and anxiety. It is a broader incumbent in prescription DTx for behavioral health and represents the scale-of-ambition benchmark Brainjo is targeting with its ADHD and anxiety assets.
• Limbic: Limbic is a UK-based digital mental health platform with AI-driven support and is exploring VR-supported therapy. It is a broader incumbent in the European digital behavioral health space overlapping with Brainjo's BJ-101 and BJ-102.
• MindMaze: MindMaze is a Swiss-based neurotechnology company building VR-based digital therapeutics for neurological and behavioral conditions. It is a broader incumbent in VR-DTx with significantly more capital and a multi-indication platform analogous to Brainjo's ambition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@brainjo-vr
• Instagraminstagram.com/brainjo.vr
• Facebookfacebook.com/Fitnessstudiofuersgehirn
• LinkedInlinkedin.com/company/brainjo

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Brainjo